Case number 2019-1607
Horizon Pharma, Inc. v. Dr. Reddy's Laboratories Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | HORIZON PHARMA, INC. v. DR. REDDY'S LABORATORIES INC. [OPINION] [nonprecedential] (0) |
| Feb 12, 2021 | 69 | Mandate issued to the United States District Court for the District of New Jersey. Service as of this date by the Clerk of Court. [755911] [19-1607, 19-1609, 19-1611, 19-1612, 19-1614] [JCP] [Entered: 02/12/2021 03:12 PM] (2) |
| Jan 6, 2021 | 68 | JUDGMENT. AFFIRMED. Terminated on the merits after submission on the briefs. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [747222] [19-1607, 19-1609, 19-1611, 19-1612, 19-1614] [JAB] [Entered: 01/06/2021 09:27 AM] (2) |
| Jan 6, 2021 | 67 | OPINION filed for the court by Moore, Circuit Judge; O'Malley, Circuit Judge and Hughes, Circuit Judge. Nonprecedential Opinion. [747221] [19-1607, 19-1609, 19-1611, 19-1612, 19-1614] [JAB] [Entered: 01/06/2021 09:25 AM] (10) |
| Jun 3, 2020 | 66 | Submitted ON THE BRIEFS. Panel: Judge: Moore , Judge: O'Malley , Judge: Hughes. [698868] [JCP] [Entered: 06/03/2020 10:33 AM] (0) |
| May 12, 2020 | 65 | ORDER filed. The oral argument scheduled for June 3, 2020, is canceled. The appeal will be submitted on the briefs without oral argument on that date. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [693725] [JAB] [Entered: 05/12/2020 08:17 AM] (2) |
| Apr 21, 2020 | 63 | NOTICE OF ORAL ARGUMENT. Panel: 2006G. Case scheduled June 3, 2020 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to Notice of Oral Argument due: 05/15/2020. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [688663] [JAB] [Entered: 04/21/2020 12:04 PM] (2) |
| Apr 20, 2020 | 64 | 6 paper copies of the Corrected Joint Appendix [54] received from Appellants Horizon Medicines LLC, Nuvo Pharmaceutical (Ireland) Designated Activity Company and Appellees Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd. [689065] [CJF] [Entered: 04/22/2020 10:29 AM] (0) |
| Apr 20, 2020 | 62 | 6 paper copies of the Reply Brief [47] received from Appellants Horizon Medicines LLC and Nuvo Pharmaceutical (Ireland) Designated Activity Company. [688372] [CJF] [Entered: 04/20/2020 03:04 PM] (0) |
| Apr 20, 2020 | 61 | 6 paper copies of the Opening Brief [33] received from Appellants Horizon Medicines LLC and Nuvo Pharmaceutical (Ireland) Designated Activity Company. [688370] [CJF] [Entered: 04/20/2020 03:03 PM] (0) |
| Apr 20, 2020 | 60 | 6 paper copies of the Corrected Opening Response Brief [44] received from Appellees Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd. [688334] [CJF] [Entered: 04/20/2020 01:47 PM] (0) |
| Apr 17, 2020 | 59 | Notice from Appellant Nuvo Pharmaceutical (Ireland) Designated Activity Company regarding conflicts with oral argument. None. Service: 04/17/2020 by email. [687785] [19-1607] [Michael Hawes] [Entered: 04/17/2020 10:15 AM] (2) |
| Apr 14, 2020 | 58 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [686794] [JAL] [Entered: 04/14/2020 12:43 PM] (0) |
| Apr 14, 2020 | 57 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [686789] [JAL] [Entered: 04/14/2020 12:37 PM] (1) |
| Mar 30, 2020 | 56 | Notice from Appellees Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd. regarding conflicts with oral argument. Service: 03/30/2020 by email. [682657] [19-1607] [John O'Quinn] [Entered: 03/30/2020 11:44 AM] (1) |
| Mar 9, 2020 | 55 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.3 to promptly submit an amended Entry of Appearance and/or update their contact information via PACER as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [677251] [JAL] [Entered: 03/09/2020 02:23 PM] (0) |
| Feb 21, 2020 | 54 | MODIFIED ENTRY: CORRECTED JOINT APPENDIX FILED for Appellants Horizon Medicines LLC and Nuvo Pharmaceutical (Ireland) Designated Activity Company and Appellees Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd. Number of Pages: 455. Service: 02/21/2020 by email. [673450] --[Edited 03/09/2020 by JAL - Compliance review complete] [Charles Collins-Chase] [Entered: 02/21/2020 06:01 PM] (455) |
| Feb 21, 2020 | 53 | Notice of Correction to Doc No. [51] for Appellants Horizon Medicines LLC and Nuvo Pharmaceutical (Ireland) Designated Activity Company. Service: 02/21/2020 by email. [673429] [19-1607] [Charles Collins-Chase] [Entered: 02/21/2020 05:25 PM] (3) |
| Feb 13, 2020 | 52 | NOTICE OF NON-COMPLIANCE: The submission of Appellants Horizon Medicines LLC, Nuvo Pharmaceutical (Ireland) Designated Activity Company and Appellees Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd., Appendix [51], is not in compliance with the rules of this court (see attached). Compliant document due on 02/21/2020. Service as of this date by the Clerk of Court. [671001] [TAM] [Entered: 02/13/2020 10:35 AM] (1) |
| Dec 19, 2019 | 51 | FILED from Appellees Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd. and Appellants Horizon Medicines LLC and Nuvo Pharmaceutical (Ireland) Designated Activity Company. Title: APPENDIX. Service: 12/19/2019 by email. [657930] [19-1607] This document is non-compliant. See Doc No.[52] [Charles Collins-Chase] [Entered: 12/19/2019 04:15 PM] (455) |
| Dec 19, 2019 | 50 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 12/19/2019 by email. [657873] [19-1607] [William Burgess] [Entered: 12/19/2019 03:27 PM] (2) |
| Dec 19, 2019 | 49 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellees Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd. and Appellants Horizon Medicines LLC and Nuvo Pharmaceutical (Ireland) Designated Activity Company. Service: 12/19/2019 by email. [657851] [19-1607] [Charles Collins-Chase] [Entered: 12/19/2019 02:38 PM] (2) |
| Dec 19, 2019 | 48 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Horizon Medicines LLC and Nuvo Pharmaceutical (Ireland) Designated Activity Company. Service: 12/19/2019 by email. [657850] [19-1607] [Charles Collins-Chase] [Entered: 12/19/2019 02:35 PM] (2) |
| Dec 12, 2019 | 47 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellants Horizon Medicines LLC and Nuvo Pharmaceutical (Ireland) Designated Activity Company. Number of Pages: 25. Service: 12/12/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [656301] --[Edited 02/13/2020 by TAM - compliance review complete] [Charles Collins-Chase] [Entered: 12/12/2019 09:19 PM] (37) |
| Nov 6, 2019 | 46 | **TEXT ONLY** ORDER granting motion to extend time to file Appellants' reply brief [45] filed by Appellants Nuvo Pharmaceutical (Ireland) Designated Activity Company and Horizon Medicines LLC. The reply brief is due 12/12/2019.. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [647450] [TAM] [Entered: 11/06/2019 03:00 PM] (0) |
| Nov 1, 2019 | 45 | MOTION of Appellants Horizon Medicines LLC and Nuvo Pharmaceutical (Ireland) Designated Activity Company to extend the time to 12/12/2019 to file the Appellants' Reply Brief. [Consent: unopposed]. Service: 11/01/2019 by email. [646501] [19-1607] [Charles Collins-Chase] [Entered: 11/01/2019 05:00 PM] (13) |
| Oct 28, 2019 | 44 | MODIFIED ENTRY: CORRECTED RESPONSE BRIEF FILED for Appellees Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd. Number of Pages: 64. Service: 10/28/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of the original version of this brief [41]. See Fed. Cir. R. 31. [645220] --[Edited 11/26/2019 by JAL - Compliance review complete] [William Burgess] [Entered: 10/28/2019 03:21 PM] (76) |
| Oct 28, 2019 | 43 | Amended Certificate of Interest for Appellees Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 10/28/2019 by email. [645219] [19-1607] [William Burgess] [Entered: 10/28/2019 03:19 PM] (4) |
| Oct 28, 2019 | 42 | NOTICE OF NON-COMPLIANCE: The submission of Appellees Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd., Response Brief [41], is not in compliance with the rules of this court (see attached). Compliant document is due on 11/04/2019. The deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [645183] [JAL] [Entered: 10/28/2019 02:28 PM] (2) |
| Oct 21, 2019 | 41 | FILED from Appellees Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd. Title: RESPONSE BRIEF. Service: 10/21/2019 by email. [643613] [19-1607] This document is non-compliant. See Doc No.[42] [William Burgess] [Entered: 10/21/2019 05:23 PM] (76) |
| Oct 2, 2019 | 40 | ORDER granting motion to extend time to file Appellees' response brief [39] filed by Appellees Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories Inc. No further extensions should be anticipated. The response brief is due 10/21/2019.. Service as of this date by the Clerk of Court. [639594] [TAM] [Entered: 10/02/2019 12:19 PM] (2) |
| Sep 23, 2019 | 39 | MOTION of Appellees Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd. to extend the time to 10/21/2019 to file the Appellees' Response Brief. [Consent: unopposed]. Service: 09/23/2019 by email. [637572] [19-1607] [William Burgess] [Entered: 09/23/2019 04:41 PM] (7) |
| Jul 16, 2019 | 38 | **TEXT ONLY** ORDER granting motion to extend time to file Appellees' response brief [37] filed by Appellees Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories Inc. Brief is due 10/07/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [621357] [TAM] [Entered: 07/16/2019 01:47 PM] (0) |
| Jul 16, 2019 | 37 | MOTION of Appellees Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd. to extend the time to 10/07/2019 to file the Appellees' Response Brief. [Consent: unopposed]. Service: 07/16/2019 by email. [621309] [19-1607] [William Burgess] [Entered: 07/16/2019 12:33 PM] (7) |
| Jul 15, 2019 | 35 | Entry of appearance for John C. O'Quinn as of counsel for Appellees Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 07/15/2019 by email. [621166] [19-1607] [John O'Quinn] [Entered: 07/15/2019 10:59 PM] (2) |
| Jul 15, 2019 | 36 | Entry of appearance for William H. Burgess as of counsel for Appellees Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 07/15/2019 by email. [621167] [19-1607] [William Burgess] [Entered: 07/15/2019 11:01 PM] (2) |
| Jul 5, 2019 | 34 | ORDER filed. The motion [32] is granted. Appeal Nos. 2019-1610 and 2019-1613 are deconsolidated and dismissed. Each side in Appeal Nos. 2019-1610 and 2019-1613 shall bear its own costs. The revised official captions are reflected in the order. ISSUED AS A MANDATE (as to 2019-1610, -1613 only): July 05, 2019. Service: 07/05/2019 by clerk. [619207] [19-1607, 19-1610, 19-1613] [LMS] [Entered: 07/05/2019 11:18 AM] (3) |
| Jun 27, 2019 | 33 | MODIFIED ENTRY: OPENING BRIEF FILED for Appellants Horizon Medicines LLC and Nuvo Pharmaceutical (Ireland) Designated Activity Company. Number of Pages: 49. Service: 06/27/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [617614] --[Edited 07/05/2019 by TAM - compliance review complete] [Charles Collins-Chase] [Entered: 06/27/2019 09:49 PM] (213) |
| Jun 20, 2019 | 32 | MOTION of Appellants Horizon Medicines LLC and Nuvo Pharmaceutical (Ireland) Designated Activity Company to withdraw party, Appellees Mylan Inc., Mylan Pharmaceuticals Inc. and Mylan Laboratories Limited, as a party to this appeal [Consent: partial consent]. Service: 06/20/2019 by email. [615926] [19-1607] [Charles Collins-Chase] [Entered: 06/20/2019 08:49 PM] (11) |
| Jun 19, 2019 | 31 | Entry of appearance for Michael Hawes as principal counsel for Appellant Nuvo Pharmaceutical (Ireland) Designated Activity Company. Service: 06/19/2019 by email. [615662] [19-1607] [Michael Hawes] [Entered: 06/19/2019 05:21 PM] (2) |
| Jun 19, 2019 | 30 | Amended Entry of appearance for Stephen M. Hash as of counsel for Appellant Nuvo Pharmaceutical (Ireland) Designated Activity Company. Service: 06/19/2019 by email. [615660] [19-1607] [Stephen Hash] [Entered: 06/19/2019 05:18 PM] (2) |
| Jun 10, 2019 | 29 | **TEXT ONLY** ORDER granting motion to extend time to file Appellants' principal brief [28] filed by Appellants Nuvo Pharmaceutical (Ireland) Designated Activity Company and Horizon Medicines LLC. Brief is due 06/27/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [612671] [TAM] [Entered: 06/10/2019 10:06 AM] (0) |
| Jun 6, 2019 | 28 | MOTION of Appellants Horizon Medicines LLC and Nuvo Pharmaceutical (Ireland) Designated Activity Company to extend the time to 06/27/2019 to file the Principal Brief. [Consent: unopposed]. Service: 06/06/2019 by email. [612220] [19-1607] [Charles Collins-Chase] [Entered: 06/06/2019 08:02 PM] (11) |
| Jun 6, 2019 | 27 | Amended Certificate of Interest for the Appellant Horizon Medicines LLC. Service: 06/06/2019 by email. [612219] [19-1607] [Charles Collins-Chase] [Entered: 06/06/2019 07:53 PM] (4) |
| Apr 25, 2019 | 26 | ORDER filed. The motion [22] is granted. The revised official caption is reflected in the order. Service: 04/25/2019 by clerk. [602983] [19-1607, 19-1609, 19-1610, 19-1611, 19-1612, 19-1613, 19-1614] [LMS] [Entered: 04/25/2019 03:03 PM] (3) |
| Apr 22, 2019 | 25 | **TEXT ONLY** ORDER granting motion to extend time to file Appellants' opening brief [24] filed by Appellants Horizon Pharma, Inc., Horizon Pharma USA, Inc. and Nuvo Pharmaceutical (Ireland) Designated Activity Company. Brief is due 06/13/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [601755] [TAM] [Entered: 04/22/2019 08:17 AM] (0) |
| Apr 19, 2019 | 24 | MOTION of Appellants Horizon Pharma USA, Inc., Horizon Pharma, Inc. and Nuvo Pharmaceutical (Ireland) Designated Activity Company to extend the time to 06/13/2019 to file the Principal Brief. [Consent: unopposed]. Service: 04/19/2019 by email. [601744] [19-1607] [Charles Collins-Chase] [Entered: 04/19/2019 07:04 PM] (15) |
| Apr 18, 2019 | 23 | Amended Entry of appearance for Alan H. Pollack as principal counsel for Appellees Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 04/18/2019 by email. [601247] [19-1607] [Alan Pollack] [Entered: 04/18/2019 12:06 PM] (1) |
| Apr 17, 2019 | 22 | MOTION of Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc. to modify the official caption [Consent: unopposed]. Service: 04/17/2019 by email. [600953] [19-1607] [Charles Collins-Chase] [Entered: 04/17/2019 11:30 AM] (11) |
| Mar 19, 2019 | 21 | Corrected Certificate of Interest for the Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc.. Service: 03/19/2019 by email. [593996] [19-1607] [Charles Collins-Chase] [Entered: 03/19/2019 03:59 PM] (4) |
| Mar 15, 2019 | 20 | NOTICE OF NON-COMPLIANCE: The submission of Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc., Certificate of Interest [14], is not in compliance with the rules of this court (see attached). Compliant document due on 03/22/2019. Service as of this date by the Clerk of Court.[593091] [TAM] [Entered: 03/15/2019 10:10 AM] (1) |
| Mar 14, 2019 | 19 | Entry of appearance for Jeffrey S. Gritton as of counsel for Appellant Nuvo Pharmaceutical (Ireland) Designated Activity Company. Service: 03/14/2019 by email. [593002] [19-1607] [Jeffrey Gritton] [Entered: 03/14/2019 09:25 PM] (2) |
| Mar 14, 2019 | 18 | Docketing Statement for the Appellant Nuvo Pharmaceutical (Ireland) Designated Activity Company. Service: 03/14/2019 by email. [593001] [19-1607] [Stephen Hash] [Entered: 03/14/2019 09:21 PM] (4) |
| Mar 14, 2019 | 17 | Certificate of Interest for the Appellant Nuvo Pharmaceutical (Ireland) Designated Activity Company. Service: 03/14/2019 by email. [593000] [19-1607] [Stephen Hash] [Entered: 03/14/2019 09:19 PM] (3) |
| Mar 14, 2019 | 16 | Entry of appearance for Stephen M. Hash as principal counsel for Appellant Nuvo Pharmaceutical (Ireland) Designated Activity Company. Service: 03/14/2019 by email. [592999] [19-1607] [Stephen Hash] [Entered: 03/14/2019 09:16 PM] (2) |
| Mar 14, 2019 | 15 | Docketing Statement for the Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc.. Service: 03/14/2019 by email. [592997] [19-1607] [Charles Collins-Chase] [Entered: 03/14/2019 09:02 PM] (4) |
| Mar 14, 2019 | 14 | Certificate of Interest for the Appellants Horizon Pharma USA, Inc., Horizon Pharma, Inc. and Not party Horizon Medicines LLC. Service: 03/14/2019 by email. [592982] [19-1607] This document is non-compliant. See Doc No. [20] [Charles Collins-Chase] [Entered: 03/14/2019 06:37 PM] (4) |
| Mar 14, 2019 | 13 | Entry of appearance for Charles T. Collins-Chase as of counsel for Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc. Service: 03/14/2019 by email. [592980] [19-1607]--[Edited 03/15/2019 by CAB to remove non-party filer] [Charles Collins-Chase] [Entered: 03/14/2019 06:33 PM] (2) |
| Mar 14, 2019 | 12 | Entry of appearance for James B. Monroe as principal counsel for Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc. Service: 03/14/2019 by email. [592979] [19-1607] --[Edited 03/15/2019 by CAB to remove non-party filer] [Charles Collins-Chase] [Entered: 03/14/2019 06:30 PM] (2) |
| Mar 14, 2019 | 11 | Docketing Statement for the Appellees Mylan Inc., Mylan Pharmaceuticals Inc. and Mylan Laboratories Limited. Service: 03/14/2019 by clerk. [592931] [19-1607] [Andrew Dufresne] [Entered: 03/14/2019 03:39 PM] (3) |
| Mar 14, 2019 | 10 | Certificate of Interest for the Appellees Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc.. Service: 03/14/2019 by clerk. [592930] [19-1607] [Andrew Dufresne] [Entered: 03/14/2019 03:37 PM] (4) |
| Mar 14, 2019 | 9 | Entry of appearance for Dan L. Bagatell as of counsel for Appellees Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc.. Service: 03/14/2019 by clerk. [592929] [19-1607] [Andrew Dufresne] [Entered: 03/14/2019 03:35 PM] (2) |
| Mar 14, 2019 | 8 | Entry of appearance for Autumn N. Nero as of counsel for Appellees Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc.. Service: 03/14/2019 by clerk. [592928] [19-1607] [Andrew Dufresne] [Entered: 03/14/2019 03:29 PM] (2) |
| Mar 14, 2019 | 7 | Entry of appearance for Shannon M. Bloodworth as principal counsel for Appellees Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc.. Service: 03/14/2019 by clerk. [592927] [19-1607] [Andrew Dufresne] [Entered: 03/14/2019 03:27 PM] (2) |
| Mar 14, 2019 | 6 | Entry of appearance for Andrew T. Dufresne as of counsel for Appellees Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc.. Service: 03/14/2019 by clerk. [592925] [19-1607] [Andrew Dufresne] [Entered: 03/14/2019 03:25 PM] (2) |
| Mar 13, 2019 | 5 | Docketing Statement for the Appellees Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 03/13/2019 by email. [592660] [19-1607] [Alan Pollack] [Entered: 03/13/2019 05:18 PM] (5) |
| Mar 13, 2019 | 4 | Certificate of Interest for the Appellees Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 03/13/2019 by email. [592659] [19-1607] [Alan Pollack] [Entered: 03/13/2019 05:17 PM] (4) |
| Mar 13, 2019 | 3 | Entry of appearance for Alan H. Pollack as principal counsel for Appellees Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 03/13/2019 by email. [592658] [19-1607] [Alan Pollack] [Entered: 03/13/2019 05:15 PM] (2) |
| Feb 28, 2019 | 2 | Note to file: The following cases are associated: 19-1607 Lead with 19-1609, 19-1610, 19-1611, 19-1612, 19-1613, and 19-1614 Member Cases. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [589369] [19-1607, 19-1609, 19-1610, 19-1611, 19-1612, 19-1613, 19-1614] [JAL] [Entered: 02/28/2019 12:24 PM] (0) |
| Feb 28, 2019 | 1 | Appeal docketed. Received: 02/22/2019. [589292]Entry of Appearance due 03/14/2019. Certificate of Interest is due on 03/14/2019. Docketing Statement due 03/14/2019. Appellants' brief is due 04/29/2019. [JAL] [Entered: 02/28/2019 10:34 AM] (33) |
